Advancing Treatment for Patients with Advanced Triple Negative Breast Cancer

Advancing Treatment for Patients with Advanced Triple Negative Breast Cancer

0 0 8 months ago
839 Plays 38 Downloads
In this edition of The Onco’Zine Brief, recorded during the Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, Illinois, June 1 - 5, 2018, Peter Hofland and Sonia Portillo talk with Michael Pehl, President and Chief Executive Officer of Immunomedics, a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC).

At this year’s ASCO meeting, nearly 40,000 attendees gathered to discuss the growing body of data on advanced, difficult to ... See More

Find us on Facebook

Copyright 2019 - Spreaker Inc. a Voxnest Company - Create a podcast - New York, NY
Help